(Q33646064)

28 July 2017

1 reference

title

Physical radiotherapy treatment planning based on functional PET/CT data (English)

1 reference

adaptive radiation therapy

28 July 2017

main subject

0 references

1

Daniela Thorwarth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673689

14 June 2024

author name string

Xavier Geets

2

1 reference

28 July 2017

Marta Paiusco

3

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673689

14 June 2024

publication date

30 July 2010

1 reference

full work available at URL

28 July 2017

https://api.elsevier.com/content/article/PII:S0167814010004032?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

https://api.elsevier.com/content/article/PII:S0167814010004032?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Radiotherapy and Oncology

14 June 2024

published in

1 reference

28 July 2017

volume

96

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

317-324

1 reference

4-dimensional computed tomography imaging and treatment planning

28 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007.

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Biological imaging in radiation therapy: role of positron emission tomography

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Molecular PET/CT imaging-guided radiation therapy treatment planning

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Hypoxia imaging-directed radiation treatment planning

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes.

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

On biologically conformal boost dose optimization

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Theragnostic imaging for radiation oncology: dose-painting by numbers

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Partial-volume effect in PET tumor imaging

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Resolution in PET hypoxia imaging: voxel size matters.

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

The promise of new PET image reconstruction

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

The limitation of PET imaging for biological adaptive-IMRT assessed in animal models

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Radiotherapy Adapted to Spatial and Temporal Variability in Tumor Hypoxia

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Hypoxia dose painting by numbers: a planning study.

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Strategies for biologic image-guided dose escalation: a review

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations.

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach

14 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors

14 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning

14 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

PET radiopharmaceuticals in radiation treatment planning – Synthesis and biological characteristics

14 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

14 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

14 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

14 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

14 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors

14 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.

14 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT?

14 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

14 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers

14 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method

14 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

14 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.RADONC.2010.07.012

14 June 2024

Identifiers

1 reference

28 July 2017

1 reference